E1308: Phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN cancer research group

Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang J. Zhao, Robert L. Ferris, William H. Westra, Jill Gilbert, Julie E. Bauman, Lynne I. Wagner, David R. Trevarthen, Jahagirdar Balkrishna, Barbara A. Murphy, Nishant Agrawal, A. Dimitrios Colevas, Christine H. Chung, Barbara Burtness

Research output: Contribution to journal › Article › peer-review

200 Scopus citations

Fingerprint

Dive into the research topics of 'E1308: Phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN cancer research group'. Together they form a unique fingerprint.

Medicine & Life Sciences